Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/107045
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | McLenachan, Samuel | - |
dc.contributor.author | Menchón Najas, Cristina | - |
dc.contributor.author | Raya Chamorro, Ángel | - |
dc.contributor.author | Consiglio, Antonella | - |
dc.contributor.author | Edel, Michael John | - |
dc.date.accessioned | 2017-02-16T10:02:39Z | - |
dc.date.available | 2017-02-16T10:02:39Z | - |
dc.date.issued | 2012-04 | - |
dc.identifier.issn | 1547-3287 | - |
dc.identifier.uri | http://hdl.handle.net/2445/107045 | - |
dc.description.abstract | The proper differentiation and threat of cancer rising from the application of induced pluripotent stem (iPS) cells are major bottlenecks in the field and are thought to be inherently linked to the pluripotent nature of iPS cells. To address this question, we have compared iPS cells to embryonic stem cells (ESCs), the gold standard of ground state pluripotency, in search for proteins that may improve pluripotency of iPS cells. We have found that when reprogramming somatic cells toward pluripotency, 1%-5% of proteins of 5 important cell functions are not set to the correct expression levels compared to ESCs, including mainly cell cycle proteins. We have shown that resetting cyclin A1 protein expression of early-passage iPS cells closer to the ground state pluripotent state of mouse ESCs improves the pluripotency and reduces the threat of cancer of iPS cells. This work is a proof of principle that reveals that setting expression of certain proteins correctly during reprogramming is essential for achieving ESC-state pluripotency. This finding would be of immediate help to those researchers in different fields of iPS cell work that specializes in cell cycle, apoptosis, cell adhesion, cell signaling, and cytoskeleton. | - |
dc.format.extent | 9 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Mary Ann Liebert | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1089/scd.2012.0190 | - |
dc.relation.ispartof | Stem Cells and Development, 2012, vol. 21, num. 15, p. 2891-2899 | - |
dc.relation.uri | https://doi.org/10.1089/scd.2012.0190 | - |
dc.rights | (c) Mary Ann Liebert, 2012 | - |
dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | - |
dc.subject.classification | Cèl·lules mare | - |
dc.subject.classification | Cèl·lules mare embrionàries | - |
dc.subject.classification | Cicle cel·lular | - |
dc.subject.classification | Transformació cel·lular | - |
dc.subject.classification | Proteïnes supressores de tumors | - |
dc.subject.other | Stem cells | - |
dc.subject.other | Embryonic stem cells | - |
dc.subject.other | Cell cycle | - |
dc.subject.other | Cell transformation | - |
dc.subject.other | Tumor suppressor protein | - |
dc.title | Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 665841 | - |
dc.date.updated | 2017-02-16T10:02:39Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 22500553 | - |
Appears in Collections: | Articles publicats en revistes (Institut de Biomedicina (IBUB)) Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
665841.pdf | 1.28 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.